Cost-Effectiveness of Adding Cardiac Resynchronization Therapy to an Implantable Cardioverter-Defibrillator Among Patients With Mild Heart Failure | Zendy

Christopher Y. Woo | Zendy; Erika Strandberg | Zendy; Michelle Schmiegelow | Zendy; Allison Pitt | Zendy; Mark A. Hlatky | Zendy; Douglas K Owens | Zendy; Jeremy D. GoldhaberFiebert | Zendy

Open Access

Cost-Effectiveness of Adding Cardiac Resynchronization Therapy to an Implantable Cardioverter-Defibrillator Among Patients With Mild Heart Failure

Author(s) -

Christopher Y. Woo,

Erika Strandberg,

Michelle Schmiegelow,

Allison Pitt,

Mark A. Hlatky,

Douglas K Owens,

Jeremy D. GoldhaberFiebert

Publication year - 2015

Publication title -

annals of internal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.839

H-Index - 390

eISSN - 1539-3704

pISSN - 0003-4819

DOI - 10.7326/m14-1804

Subject(s) - medicine , cardiac resynchronization therapy , heart failure , ejection fraction , implantable cardioverter defibrillator , cardiology , cost effectiveness , qrs complex , life expectancy , population , emergency medicine , risk analysis (engineering) , environmental health

Cardiac resynchronization therapy (CRT) reduces mortality and heart failure hospitalizations in patients with mild heart failure.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research